BULLISHWHALES
BullishWhales · Congress · Trade Detail
NASDAQ: GMABGenmab AS
RepublicanHouse

James B. Renacci sold Genmab AS (NASDAQ: GMAB)

James B. Renacci (R-OH), a U.S. Representative, has disclosed 2 trades in Genmab AS (GMAB) since 2018, 1 purchase and 1 sale, worth an estimated $65K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: James B. Renacci sold $15,001 - $50,000 of Genmab AS (NASDAQ: GMAB) on December 12, 2018. Since that trade, GMAB is up +75.12% against the S&P 500 up +217.40%, an outperformance of -142.28%.

Across these filings, James B. Renacci has been a balanced trader of GMAB (a buy-to-sell ratio of 1.00). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

GMAB trades
2
Disclosed Vol
$65K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2018

James B. Renacci's GMAB trades vs the price

GMAB is up +75.12% since James B. Renacci sold on December 12, 2018, versus +217.40% for the S&P 500.

Performance since this trade

Price change since trade
+75.12%
S&P 500 change since trade
+217.40%
Outperformance vs S&P 500
-142.28%

All James B. Renacci GMAB trades

TradedTypeSizeReturnEst. profit
December 12, 2018SELL$15.99+75.12%
February 28, 2018BUY$20.80+34.66%-$24K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

James B. Renacci & GMAB trading FAQ

Is it legal for James B. Renacci to trade Genmab AS (GMAB) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Genmab AS (GMAB), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.

When did James B. Renacci sell GMAB?

James B. Renacci disclosed a sale of $15,001 - $50,000 of Genmab AS (GMAB) on December 12, 2018, according to public STOCK Act filings.

How has GMAB performed since James B. Renacci's trade?

Since James B. Renacci sold GMAB on December 12, 2018, the stock is up +75.12%, versus +217.40% for the S&P 500 over the same period, an outperformance of -142.28%.

How many times has James B. Renacci traded GMAB?

James B. Renacci has disclosed 2 GMAB trades since 2018 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional GMAB trades?

BullishWhales tracks every disclosed congressional trade in Genmab AS (GMAB) on the Genmab AS congressional trading page, which aggregates filings across all members of Congress.

James B. Renacci's GMAB tradesAll congressional filings for Genmab ASJames B. Renacci's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30